- ImmunoGen Announces Webcast of Presentation and Q&A at Upcoming Guggenheim Nantucket Therapeutics Conference
- ImmunoGen Presents Additional Analyses Evaluating Mirvetuximab Soravtansine in Ovarian Cancer at ESMO
- ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- ImmunoGen Provides Update on Pivotal CADENZA Study of Pivekimab Sunirine in Frontline Blastic Plasmacytoid Dendritic Cell Neoplasm
- ImmunoGen Reports Recent Progress and Second Quarter 2022 Financial Results
- ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2022 Operating Results
ImmunoGen Inc (IMGN:NSQ) closed at 4.48, 44.75% above the 52 week low of 3.10 set on Jun 14, 2022.
3.10Jun 14 20227.77Dec 01 2021
Markit short selling activity
|Market cap||1.01bn USD|
|EPS (TTM)||-0.6907 |
Data delayed at least 15 minutes, as of Sep 26 2022 21:00 BST.